Literature DB >> 19487474

Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans.

Kerstin Voelz1, David A Lammas, Robin C May.   

Abstract

The pathogenic yeast Cryptococcus neoformans and C. gattii commonly cause severe infections of the central nervous system in patients with impaired immunity but also increasingly in immunocompetent individuals. Cryptococcus is phagocytosed by macrophages but can then survive and proliferate within the phagosomes of these infected host cells. Moreover, Cryptococcus is able to escape into the extracellular environment via a recently discovered nonlytic mechanism (termed expulsion or extrusion). Although it is well established that the host's cytokine profile dramatically affects the outcome of cryptococcal disease, the molecular basis for this effect is unclear. Here, we report a systematic analysis of the influence of Th1, Th2, and Th17 cytokines on the outcome of the interaction between macrophages and cryptococci. We show that Th1 and Th17 cytokines activate, whereas Th2 cytokines inhibit, anticryptococcal functions. Intracellular yeast proliferation was significantly lower after treatment with the Th1 cytokines gamma interferon and tumor necrosis factor alpha and the Th17 cytokine interleukin-17 (IL-17). Interestingly, however, the Th2 cytokines IL-4 and IL-13 significantly increased intracellular yeast proliferation while reducing the occurrence of pathogen expulsion. These results help explain the observed poor prognosis associated with the Th2 cytokine profile (e.g., in human immunodeficiency virus-infected patients).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487474      PMCID: PMC2715691          DOI: 10.1128/IAI.00297-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions.

Authors:  M Altfeld; M M Addo; K A Kreuzer; J K Rockstroh; F L Dumoulin; K Schliefer; L Leifeld; T Sauerbruch; U Spengler
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

2.  Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Authors:  D L Goldman; S C Lee; A J Mednick; L Montella; A Casadevall
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm.

Authors:  Stephanie C Tucker; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.

Authors:  D O Beenhouwer; S Shapiro; M Feldmesser; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 5.  Intracellular parasitism of macrophages by Cryptococcus neoformans.

Authors:  M Feldmesser; S Tucker; A Casadevall
Journal:  Trends Microbiol       Date:  2001-06       Impact factor: 17.079

6.  Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.

Authors:  K Kawakami; M Hossain Qureshi; T Zhang; Y Koguchi; Q Xie; M Kurimoto; A Saito
Journal:  Cell Immunol       Date:  1999-10-10       Impact factor: 4.868

7.  Enhancement of antifungal chemotherapy by interferon-gamma in experimental systemic cryptococcosis.

Authors:  J E Lutz; K V Clemons; D A Stevens
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

8.  Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Authors:  M Feldmesser; Y Kress; P Novikoff; A Casadevall
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

9.  Efficacy of recombinant gamma interferon for treatment of systemic cryptococcosis in SCID mice.

Authors:  K V Clemons; J E Lutz; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

10.  Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.

Authors:  F J Swenson; T R Kozel
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

View more
  91 in total

1.  Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.

Authors:  Sarah E Hardison; Karen L Wozniak; Jay K Kolls; Floyd L Wormley
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

Review 2.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

3.  The Outcome of the Cryptococcus neoformans-Macrophage Interaction Depends on Phagolysosomal Membrane Integrity.

Authors:  Carlos M De Leon-Rodriguez; Diego C P Rossi; Man Shun Fu; Quigly Dragotakes; Carolina Coelho; Ignacio Guerrero Ros; Benjamin Caballero; Sabrina J Nolan; Arturo Casadevall
Journal:  J Immunol       Date:  2018-06-01       Impact factor: 5.422

4.  Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.

Authors:  Pornpimon Angkasekwinai; Nuntarat Sringkarin; Oratai Supasorn; Madtika Fungkrajai; Yui-Hsi Wang; Methee Chayakulkeeree; Popchai Ngamskulrungroj; Nasikarn Angkasekwinai; Kovit Pattanapanyasat
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

Review 5.  Fungal Pathogens: Survival and Replication within Macrophages.

Authors:  Andrew S Gilbert; Robert T Wheeler; Robin C May
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

6.  Visualizing non-lytic exocytosis of Cryptococcus neoformans from macrophages using digital light microscopy.

Authors:  Sabriya Stukes; Arturo Casadevall
Journal:  J Vis Exp       Date:  2014-10-21       Impact factor: 1.355

7.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

8.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

9.  Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection.

Authors:  Sarah E Hardison; Sailatha Ravi; Karen L Wozniak; Mattie L Young; Michal A Olszewski; Floyd L Wormley
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

10.  Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Sailatha Ravi; Sandra Macias; Mattie L Young; Michal A Olszewski; Chad Steele; Floyd L Wormley
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.